Steven J. Greenberg,Bernhard K. Mueller,Andreas Popp,Matthew R. Rosebraugh,George M. Haig,Shao-Lee Lin
申请号：
US16138486
公开号：
US20190247503A1
申请日:
2018.09.21
申请国别(地区):
US
年份:
2019
代理人:
摘要：
Disclosed herein are anti-RGMa antibodies and methods of using these antibodies to treat multiple sclerosis, including relapsing forms of multiple sclerosis such as relapsing-remitting multiple sclerosis or relapsing-secondary progressive multiple sclerosis.
